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SUMMARY · The study was performed to provide current resistance data on gram-positive patho-
gens at the Sestre milosrdnice University Hospital in Zagreb. The organisms selected for monitoring
of antimicrobial resistance to different antibiotics included Streptococcus pneumoniae, Streptococcus
pyogenes, methicillin sensitive and resistant Staphylococcus aureus, and Enterococcus sp., isolated from
different clinical specimens of hospitalized adults and children from various Hospital wards. The
antibiotic sensitivity testing was performed by disk diffusion and E-test method. Resistance of Strep-
tococcus pneumoniae to penicillin was found to be of great importance. It was quite common but
moderate, so penicillin remained an appropriate choice in empirical therapy for presumed pneumo-
coccal respiratory infections. Resistance of Streptococcus pyogenes to azithromycin was also quite sig-
nificant, posing a question whether macrolides were an appropriate choice in empirical therapy for
presumed Streptococcus pyogenes tonsillopharyngitis. As many as 38% of Enterococcus sp. could not be
treated by a combination of penicillin or glycopeptide and gentamicin because of the high · lerel
resistance to gentamicin. Resistance to antibiotics in methicillin sensitive Staphylococcus aureus was
not observed. Antibiotic resistance data on gram-positive pathogens influence the choice of local
empirical therapy and allow for a more rational use of antibiotics at a hospital.
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Introduction
Antibiotic resistance is among the most challenging
problems in microbiology and clinical medicine. Bacte-
ria have a remarkable ability to mutate and acquire resis-
tant genes from other organisms and thereby develop re-
sistance to antibiotics. When an antibiotic is used, the
selective pressure exerted by the drug favors the growth
of organisms with mutations that allow them to resist the
drug action. The extensive use of antibiotics has resulted
in the emergence of drug resistance that threatens at the
beginning of the new millennium1. Examples of clinically
important gram-positive bacteria that are rapidly devel-
oping resistance to available antibiotics include bacteria
that cause pneumonia, ear infections, and meningitis (e.g.,
Streptococcus pneumoniae)2, skin, bone, lung and blood-
stream infections (e.g., Staphylococcus aureus)3, urinary tract
and surgical wound infections (enterococci)4.
The study was performed to provide current resistance
data on gram-positive pathogens at the Sestre milosrdnice
University Hospital in Zagreb.
Material and Methods
Antibiotic resistance of gram-positive bacteria was
monitored for six consecutive months (from January 1 till
June 30, 2000). The organisms selected for surveillance
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included Streptococcus pneumoniae, Streptococcus pyogenes
(beta-hemolytic streptococcus group A), Enterococcus sp.,
methicillin sensitive Staphylococcus aureus, and methicillin
resistant Staphylococcus aureus. These organisms were iso-
lated from different clinical specimens of adult and pedi-
atric inpatients from different Hospital wards. Duplicate
or multiple isolates of the selected species were not exclu-
ded from the study.
All organisms were identified according to colony
morphology and Gram stain. Identification of Streptococ-
cus pneumoniae was confirmed by optochin susceptibility
test. Bacitracin susceptibility test was used in identifica-
tion of Streptococcus pyogenes. Esculin hydrolysis test was
used in identification of enterococcal species. DNase test
and slide coagulase test were used for identification of
Staphylococcus aureus5.
Antibiotic sensitivity testing was performed by the
disk diffusion method according to National Committee
for Clinical Laboratory Standard (NCCLS) procedures.
Antibiotics were selected individually for each of the or-
ganisms selected. Sensitivity of Streptococcus pneumoniae
to penicillin was determined by 1-µg oxacillin test. E-test
penicillin G method was used for the pneumococcal
strains that were resistant to oxacillin. In oxacillin resis-
tant strains, the sensitivity of Streptococcus pneumoniae to
ceftriaxone was determined by E-test ceftriaxone method.
The sensitivity of Staphylococcus aureus to beta-lactams was
determined by 1-µg oxacillin disk. In enterococcal species,
the high-level resistance to aminoglycosides was determi-
ned by 120-µg gentamicin disk6,7.
Results
Percentage of resistance of different bacteria to differ-
ent antibiotics is presented in Tables 1-5.
Streptococcus pneumoniae (Table 1a, 1b). Most pneumo-
coccal isolates were isolated from respiratory specimens
and nasopharyngeal swabs, in pediatric patients, pediat-
ric rehabilitation patients, ear-nose-throat (ENT) pa-
tients, and pulmonology patients. The disk diffusion
method revealed pneumococcal resistance to penicillin to
be quite common, with an average of 53%. Approximately
97% of penicillin resistant pneumococcal strains showed
moderate resistance (MIC 0.12-1.0 µg/ml) and only 3%
high resistance (MIC >2 µg/ml) to penicillin when tested
by E-test penicillin G method. The average resistance to
cotrimoxazole was 47%, to azithromycin 22%, and to tet-
racycline 33%. The average resistance to ceftriaxone as
determined in oxacillin resistant strains was 22%. Like-
wise penicillin resistance, ceftriaxone resistance in pneu-
mococcal strains was moderate (MIC 1 mg/ml) when
tested by E-test ceftriaxone method.
Table 1a. Percentage of resistance in Streptococcus pneumoniae
Antibiotic PEN AZI SXT TE
No. of
isolates tested 217 218 225 218
Ward:
Pediatrics 49 23 48 39
Children
rehabilitation 42 15 54 8
Ear-nose-throat 63 32 55 41
Pulmonology   50 8 33 17
Total 53 22 47 33
PEN=penicillin; AZI=azithromycin; SXT=cotrimoxazole;
TE=tetracycline
Table 1b. Percentage of ceftriaxone resistance in oxacillin
resistant Streptococcus pneumoniae
Antibiotic CRO









Streptococcus pyogenes (Table 2). Most isolates of Strep-
tococcus pyogenes were isolated from throat and nasopha-
ryngeal swabs in pediatric patients, ENT patients, pedi-
atric rehabilitation patients, and internal medicine pa-
tients. The average azithromycin resistance was 17%. Pe-
nicillin resistance did not occur.
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Table 2. Percentage of penicillin and azithromycin
resistance in Streptococcus pyogenes
Antibiotic PEN AZI
No. of isolates tested 22 18
Ward:
Pediatrics 0 20
Children rehabilitation 0 25
Ear-nose-throat 0 0




Table 3. Percentage of resistance in Enterococcus sp.
Antibiotic AMP GE VA
No. of isolates tested 421 419 116
Ward:
Internal medicine 7 44 0
Surgery 8 37 0
Neurology 7 28 0
Pediatrics 19 33 0
Urology 10 24 0
Dermatology 6 35 0
Others
Total 9 38 0
AMP=ampicillin; GE=gentamicin; VA=vancomycin
Enterococcus sp. (Table 3). Most isolates of Enterococ-
cus sp. were isolated from urine, wound swabs, and blood
specimens from internal medicine, surgery, neurology, pe-
diatrics, urology and dermatology patients. Nine percent
of all enterococcal isolates were resistant to ampicillin,
while an average of 38% isolates showed high level gen-
tamicin resistance. Resistance to vancomycin did not oc-
cur.
Methicillin sensitive Staphylococcus aureus (Table 4).
Most isolates of methicillin sensitive Staphylococcus aureus
were isolated from wound swab, tracheal aspirate, naso-
pharyngeal swabs and blood specimens in pediatrics, in-
ternal medicine, surgery, dermatology, ENT, and neurolo-
gy patients. An average resistance to clindamycin (4%),
azithromycin (7%), cotrimoxazole (3%), ciprofloxacin
(16%), gentamicin (6%) and mupirocin (13%) was recor-
ded. Resistance to rifampicin and vancomycin did not
occur.
Methicillin resistant Staphylococcus aureus (Table 5).
Most isolates of methicillin resistant Staphylococcus aureus
were isolated from wound swabs, blood, tracheal aspirate
and other respiratory specimens in surgery, internal medi-
cine, neurology, pulmonology, and neurosurgery patients.
Methicillin resistant strains often showed multiple resis-
tance, with an average resistance of 98% to clindamycin,
99% to both azithromycin and ciprofloxacin, and 100% to
gentamicin. Average resistance to rifampicin was 18%, and
to cotrimoxazole 2%. Resistance to mupirocin and van-
comycin was not recorded.
Table 4. Percentage of resistance in methicillin sensitive Staphylococcus aureus
Antibiotic OX CC RIF AZI SXT CIP GE MUP VA
No. of isolates tested 309 244 23 299 308 50 284 107 27
Ward:
Pediatrics 0 0 0 9 0 2 0 1 0
Internal medicine 0 4 0 3 4 4 5 3 0
Surgery 0 3 0 5 3 3 3 0 0
Dermatology 0 0 0 10 8 0 15 23 0
Ear-nose-throat 0 22 0 28 11 6 11 6 0
Neurology 0 0 0 0 0 0 9 9 0
Others
Total 0 4 0 7 3 16 6 13 0
OX=oxacillin; CC=clindamycin; RIF=rifampicin; AZI=azithromycin; SXT=cotrimoxazole; CIP=ciprofloxacin; GE=gentamicin;
MUP=mupirocin; VA=vancomycin
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Discussion
This type of antibiotic resistance surveillance study
provides data of great concern for clinicians. These data
warn of the emergence of resistance among gram-positive
pathogens. Our results showed percentage resistance of
different gram-positive pathogens to different antibiot-
ics. There were differences in the antibiotic resistance of
different gram-positive pathogens from different Hospi-
tal wards. Data obtained by local antibiotic resistance sur-
veillance are used to design empirical therapy at the hos-
pital as a whole or at a particular ward, at the same time
introducing a more rational use of antibiotics. This was
the final goal of our study, i.e. to design local empirical
therapy, thus to discourage misuse and overuse of antibio-
tics in empirical therapy.
Of great importance is the problem of Streptococcus
pneumoniae resistance to penicillin. Moderate resistance
of Streptococcus pneumoniae to penicillin at the Hospital
was found to be very common, with an average of 53%.
High resistance to penicillin was quite infrequent (3%).
Because of as yet uncommon high penicillin resistance of
pneumococcal isolates at the Hospital, penicillin remained
an appropriate choice in empirical therapy for presumed
pneumococcal respiratory infections. An average of 22%
of Streptococcus pneumoniae strains resistant to azithro-
mycin point to the problem of an increasing resistance to
macrolides, and raise the question of whether macrolides
should be used as antibiotics in empirical therapy for pre-
sumed pneumococcal infections. National data on Strep-
tococcus pneumoniae resistance were issued by the Croatian
Committee for Antibiotic Resistance Surveillance for the
year 1997. At the national level, the average resistance to
penicillin was 37% and to azithromycin 12%, however,
quite a high resistance was recorded in some parts of
Croatia8. At our Hospital, moderate resistance to ceftria-
xone among oxacillin resistant strains of Streptococcus pneu-
moniae averaged to 22%. In the Latin American Surveil-
lance and Epidemiology Research Study of susceptibility
of 1100 pneumococcal strains, Jacobs et al. report on 12%
of pneumococcal strains moderately resistant to penicil-
lin to be resistant to ceftriaxone, and even 88% of strains
highly resistant to penicillin to be resistant to ceftriaxone9.
At our Hospital, penicillin resistance was not observed
in Streptococcus pyogenes, however, an average 17% resis-
tance to azithromycin is considered significant. Therefore,
the question should be posed again: are macrolides appro-
priate antibiotics in empirical therapy for presumed Strep-
tococcus pyogenes tonsillopharyngitis?
The average resistance of Enterococcus sp. to ampicil-
lin was very similar to that reported at the national level8,
however, the average of 38% of high resistance to gentami-
cin appears to be quite a disturbing finding, implying that
38% of Enterococcus sp. cannot be treated by a combina-
tion of penicillin or glycopeptide and gentamicin in case
of systemic enterococcal infections. When an enterococ-
cal strain is highly resistant to the aminoglycoside gen-
tamicin, there is no synergism, and combination therapy
will not exert bactericidal effect5. No isolate resistant to
vancomycin was recorded.
Resistance to antibiotics in methicillin sensitive Sta-
phylococcus aureus was relatively uncommon. Resistance to
mupirocin, an antibiotic for topical treatment of staphy-
lococcal superficial soft tissue infections, showed an av-
Table 5. Percentage of resistance in methicillin resistant Staphylococcus aureus
Antibiotic OX CC RIF AZI SXT CIP GE MUP VA
No. of isolates tested 247 172 131 218 250 155 242 60 211
Ward:
Surgery 100 67 8 85 1 59 100 0 0
Internal medicine 100 82 15 85 4 70 100 0 0
Neurology 100 42 0 95 0 63 100 0 0
Pulmonology 100 60 27 87 7 67 100 0 0
Neurosurgery 100 100 0 100 0 25 100 0 0
Total 100 98 18 99 2 99 100 0 0
OX=oxacillin; CC=clindamycin; RIF=rifampicin; AZI=azithromycin; SXT=cotrimoxazole; CIP=ciprofloxacin; GE=gentamicin;
MUP=mupirocin; VA=vancomycin
I. BenËiÊ and I. BenËiÊ Antibiotic resistance of gram positive bacteria
Acta clin Croat, Vol. 40, No. 1, 2001 19
erage of 13%. These data differ from the Croatian national
data8, and may have resulted from the overuse of mupi-
rocin at some of the Hospital wards.
Methicillin resistant Staphylococcus aureus showed an
average resistance of 98% to clindamycin, and 99% to
azithromycin and ciprofloxacin each. There was no iso-
late resistant to vancomycin.
Conclusion
The antibiotic resistance data on gram-positive patho-
gens at different wards of a hospital will warn clinicians
of the presence and emergence of antimicrobial resistance,
thus influencing the choice of local empirical therapy and
resulting in a more appropriate and more rational use of
antibiotics. Clinicians should be kept informed about the
problems of drug resistance at their wards and in commu-
nities in general, to help them prescribe appropriate drugs
and avoid therapeutic failure.
Resistance of gram-positive pathogens will be con-
tinuously monitored, and predominant trends and varia-
tion in the rate of antimicrobial resistance will hopefully
be recognized and interpreted in additional studies.
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Saæetak
OTPORNOST GRAM-POZITIVNIH BAKTERIJA NA ANTIBIOTIKE U KLINI»KOJ BOLNICI “SESTRE
MILOSRDNICE”
I. BenËiÊ i I. BenËiÊ
Cilj istraæivanja bio je pratiti otpornost gram-pozitivnih uzroËnika na antibiotike u KliniËkoj bolnici “Sestre milosrdnice”
u Zagrebu. Otpornost na antibiotike pratila se za sljedeÊe gram-pozitivne uzroËnike: Streptococcus pneumoniae, Streptococcus
pyogenes, na meticilin osjetljiv i rezistentan Staphylococcus aureus te Enterococcus sp., koji su izolirani iz kliniËkih materijala
hospitaliziranih odraslih osoba i djece. Testiranje osjetljivosti na antibiotike provedeno je pomoÊu difuzijske metode i E-
testom. Vrlo je znaËajan bio problem otpornosti Streptococcus pneumoniae na penicilin. Ova je otpornost bila vrlo Ëesta, ali je
umjerena, ¹to znaËi da penicilin i dalje ostaje prikladnim antibiotikom u empirijskoj terapiji pretpostavljenih pneumokoknih
respiracijskih infekcija. Otpornost Streptococcus pyogenes na azitromicin bila je takoðer znaËajna, pa se postavlja pitanje jesu li
makrolidi prikladni antibiotici u empirijskoj terapiji gnojnih angina. »ak 38% Enterococcus sp. ne moæe se lijeËiti kombinacijom
penicilina ili glikopeptida i gentamicina zbog visoke otpornosti enterokoka na gentamicin. Otpornost na antibiotike kod
Staphylococcus aureus osjetljivih na meticilin nije bila Ëesta. Otpornost na vankomicin kod Staphylococcus aureus otpornih na
meticilin nije zabiljeæena. Podaci o otpornosti gram-pozitivnih uzroËnika na antibiotike utjeËu na izbor lokalne empirijske
terapije i omoguÊavaju racionalniju potro¹nju antibiotika u bolnici.
KljuËne rijeËi: Gram-pozitivne bakterije, uËinak lijekova; Otpornost na lijekove, mikrobni; Bakterijske infekcije, mikrobiologija
